Document Detail


Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
MedLine Citation:
PMID:  18957398     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this study was to evaluate the occurrence and dissemination of acquired carbapenem-hydrolysing class D beta-lactamase (class D carbapenemase)- and metallo-beta-lactamase (MBL)-encoding genes among Acinetobacter spp. isolates recovered from medical centres in the Asia-Pacific (APAC) region. METHODS: During 2006-07, 41 medical centres located in 10 countries in the APAC region forwarded to a central monitoring site 544 Acinetobacter spp. isolates, which were tested for susceptibility by the reference broth microdilution method. Isolates non-susceptible to imipenem or meropenem (MIC>or=8 mg/L) were screened for OXA-23-, OXA-24/40-, OXA-58- and MBL-encoding genes and confirmed by sequencing. Clonality was assessed by ribotyping and PFGE. RESULTS: Polymyxins (99.1% susceptible) and tigecycline (98.9% susceptible) were the most active antimicrobial agents tested. Among the isolates, 230 (42.3%) were non-susceptible to imipenem or meropenem, and class D carbapenemase- or MBL-encoding genes were detected in 162 (70.4%). blaOXA-23 was found in isolates recovered from six countries, while blaOXA-24/40 and blaOXA-58 were less common. Several isolates harboured more than one class D carbapenemase, and MBL-encoding genes were detected in one Acinetobacter johnsonii from the Philippines (blaIMP-4) and one Acinetobacter baumannii from Korea (blaVIM-2)). Overall, clonal dissemination was noted within medical centres; however, genetic relatedness was also noted among class D carbapenemase-producing A. baumannii isolates recovered from different countries. CONCLUSIONS: This study shows a high distribution of class D carbapenemase-encoding genes, mainly blaOXA-23, in Acinetobacter spp. isolates. In addition, clonal dissemination among medical centres located in different countries in the APAC region, previously documented in many regions of Europe, emphasizes the epidemic potential of these bacteria.
Authors:
Rodrigo E Mendes; Jan M Bell; John D Turnidge; Mariana Castanheira; Ronald N Jones
Related Documents :
11284028 - Is (9z)-"meso"-zeaxanthin optically active?
16701828 - Synthesis of biocompatible segmented polyurethanes from aliphatic diisocyanates and diu...
18397168 - Biosynthesis of enediyne antitumor antibiotics.
8756398 - Structural determinants of cobrotoxin for binding to an enzyme-linked-immunoassay plate.
4009338 - Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid ce...
10212358 - Recent deliberations of the association for the advancement of medical instrumentation'...
Publication Detail:
Type:  Journal Article     Date:  2008-10-27
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  63     ISSN:  1460-2091     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-16     Completed Date:  2009-01-23     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  England    
Other Details:
Languages:  eng     Pagination:  55-9     Citation Subset:  IM    
Affiliation:
JMI Laboratories, North Liberty, IA 52317, USA. rodrigo-mendes@jmilabs.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acinetobacter / classification,  drug effects*,  enzymology*,  isolation & purification
Acinetobacter Infections / epidemiology*,  microbiology*
Anti-Bacterial Agents / pharmacology*
Asia / epidemiology
Australasia
Bacterial Typing Techniques
Cluster Analysis
DNA Fingerprinting
DNA, Bacterial / genetics
Electrophoresis, Gel, Pulsed-Field
Genotype
Humans
Microbial Sensitivity Tests
Molecular Epidemiology
Ribotyping
beta-Lactam Resistance*
beta-Lactamases / biosynthesis*,  genetics
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/DNA, Bacterial; EC 3.5.2.6/beta-Lactamases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Emergence of Qnr determinants in human Salmonella isolates in Taiwan.
Next Document:  A study of the relationship between job satisfaction, organizational commitment and turnover intenti...